| Literature DB >> 34672226 |
Yeong-Mi Seong1, Hyejin Lee2, Ji Min Seo2.
Abstract
We developed and tested the effectiveness of an algorithm to prevent medical device-related pressure injuries in intensive care unit patients. It was developed in four stages: literature review and analysis of medical records; preliminary algorithm development; validation of the preliminary algorithm by experts in two rounds; and practical feasibility verification of the revised algorithm by 109 intensive care unit nurses. To verify the algorithm's effectiveness, we compared the incidence of medical device-related pressure injuries between 324 patients without algorithm application (control group) and 312 patients with algorithm application (experimental group). The outcomes were skin inspection of the medical device attachment, pressure injury evaluation, and implementation of pressure injury-preventive nursing care, based on the medical device type. The incidence rates were 1.46 per 100 devices (control group) and 1.19 per 100 devices (experimental group). Since there was no homogeneity in the previous score of the Braden scale in the experimental and control groups, the results regarding the incidence of pressure damage after applying the algorithm should be interpreted with care. Applying this algorithm was a safe intervention that helped prevent medical device-related pressure injuries in this population.Entities:
Keywords: algorithm; equipment and supplies; intensive care unit; pressure ulcer
Mesh:
Year: 2021 PMID: 34672226 PMCID: PMC8543706 DOI: 10.1177/00469580211050219
Source DB: PubMed Journal: Inquiry ISSN: 0046-9580 Impact factor: 1.730
Figure 1.Development and testing of a medical device–related pressure injury prevention algorithm for patients admitted to intensive care units using a modified four-stage clinical practice guideline.
Figure 2.Keywords used in the search strategy.
Figure 3.Flowchart of the study selection process. CINAHL, Cumulative Index to Nursing and Allied Health Literature; NGC, National Guideline Clearinghouse; RISS, Research Information Sharing Service; KCI, Korea Citation Index; KoMGI, Korean Medical Guideline Information Center.
Results of the Verification of the Feasibility of Nurses’ Practice (N = 109).
| Content | Mean Score ± SD |
|---|---|
| Early detection of MDRPI is possible using the algorithm. | 3.41 ± .55 |
| Use of the algorithm reduced the omission of nursing intervention to prevent and manage MDRPI. | 3.40 ± .63 |
| The use of the algorithm will help new nurses in MDRPI prevention through nursing care. | 3.37 ± .50 |
| The algorithm can be easily used by nurses with different experience levels from new nurses to experienced nurses. | 3.35 ± .50 |
| The use of the algorithm has increased awareness and interest in MDRPI prevention and management. | 3.32 ± .54 |
| The use of the algorithm has increased the implementation of nursing interventions for MDRPI prevention and management. | 3.31 ± .56 |
| Through the algorithm, the flow of preventive and nursing care of MDRPI can be easily grasped. | 3.29 ± .58 |
| The use of the algorithm can provide evidence-based MDRPI prevention nursing care. | 3.28 ± .49 |
| The prevention and management of MDRPI using the algorithm improves the quality of nursing. | 3.27 ± .52 |
| The use of the algorithm has increased the consistency and accuracy of nursing work for MDRPI prevention and management. | 3.21 ± .56 |
| The algorithm facilitates MDRPI prevention and facilitates more efficient nursing care for MDRPI patients. | 3.20 ± .56 |
| The use of the algorithm has increased the knowledge of MDRPI prevention and management. | 3.14 ± .55 |
| The use of the algorithm reduced the burden on the nurse in-charge through MDRPI prevention and management. | 2.75 ± .76 |
SD, standard deviation; MDRPI, medical device–related pressure injury.
Figure 4.The final medical device–related pressure-injury-prevention algorithm.
Comparison of the Incidence Site, Stage, and Frequency of Pressure Injury by Type of Medical Device between the Experimental Group and the Control Group (N = 636).
| Medical Device | Incidence Site | PI stage | PI Frequency | PI stage | PI Frequency |
|---|---|---|---|---|---|
| Control (N = 324) | Experimental (N = 312) | ||||
| Restraint | Hand and arm | DTPI | 1 | DTPI | 1 |
| 0 | Stage 2 | 1 | |||
| Pulse oximetry | Ear | Stage 2 | 2 | 0 | |
| Endotracheal tube | Face | DTPI | 2 | MM | 1 |
| Stage 2 | 1 | DTPI | 1 | ||
| Lip or tongue | MMPI | 1 | MMPI | 2 | |
| Unstageable | 1 | 0 | |||
| Nasogastric tube | Nose | Stage 2 | 3 | Stage 2 | 1 |
| IPC | Leg | DTPI | 11 | DTPI | 8 |
| Unstageable | 1 | Stage 2 | 2 | ||
| PCD | Flank | 0 | Stage 2 | 1 | |
| Optiflow
| Ear | DTPI | 2 | Stage 1 | 2 |
| Arterial catheter | Hand and arm | Stage 2 | 1 | 0 | |
| Mask | Ear | 0 | Stage 2 | 1 | |
| Nasotracheal tube | Nose | MMPI | 1 | 0 | |
| IV catheter | Leg | Unstageable | 1 | 0 | |
| 0 | Stage 2 | 1 | |||
DTPI, deep tissue pressure injury; IPC, intermittent pneumatic compression device; IV, intravenous; MDRPI, medical device–related pressure injury; MMPI, mucosal membrane pressure injury; PCD, percutaneous catheter drainage; PI, pressure injury.
Control group: the algorithm was not applied to these patients.
Experimental group: the algorithm was applied to these patients.
aOptiflow, a high-flow nasal oxygen delivery system, is manufactured by Fisher & Paykel Healthcare, Inc (Irvine, CA, USA).
Incidence of Pressure Injury between the Experimental Group and the Control Group (N = 3759).
| Medical Device | Control (N = 1915) | Experimental (N = 1844) |
|---|---|---|
| Incidence ( | Incidence ( | |
| IPC | 12 (.6) | 10 (.5) |
| Endotracheal tube | 5 (.3) | 4 (.2) |
| Nasogastric tube | 3 (.2) | 1 (.1) |
| Optiflow
| 2 (.1) | 2 (.1) |
| Pulse oximetry | 2 (.1) | 0 (.0) |
| Arterial catheter | 1 (.1) | 0 (.0) |
| Nasotracheal tube | 1 (.1) | 0 (.0) |
| Restraint | 1 (.1) | 2 (.1) |
| IV catheter | 1 (.1) | 0 (.0) |
| PCD | 0 (.0) | 1 (.1) |
| CVC | 0 (.0) | 1 (.1) |
| Mask | 0 (.0) | 1 (.1) |
| Total | 28 (1.5) | 22 (1.2) |
CVC, central venous catheter; IPC, intermittent pneumatic compression device; IV, intravenous; MDRPI, medical device–related pressure injury; PCD, percutaneous catheter drainage
Control group: the algorithm was not applied to these patients.
Experimental group: the algorithm was applied to these patients.
aOptiflow, a high-flow nasal oxygen delivery system, is manufactured by Fisher & Paykel Healthcare, Inc (Irvine, CA, USA).